Match!
Kartik Shenoy
Temple University
CardiologyIntensive care medicineCOPDExacerbationMedicine
28Publications
5H-index
119Citations
What is this?
Publications 28
Newest
#1Victor Kim (TU: Temple University)H-Index: 23
#2H. Zhao (TU: Temple University)H-Index: 4
Last. Mario E. RuizH-Index: 5
view all 152 authors...
Background Chronic bronchitis (CB) increases risk of COPD exacerbations. We have shown that the St. George’s Respiratory Questionnaire (SGRQ) CB definition identifies patients with a similar clinical phenotype as classically defined CB. Whether the SGRQ CB definition is a predictor of future COPD exacerbations is unknown. Methods We analyzed 7,557 smokers with normal spirometry and Global Initiative for Chronic Obstructive Lung Disease stage 1-4 COPD in the Genetic Epidemiology of COPD study wit...
1 CitationsSource
Source
#1D. Baumgarten (TU: Temple University)
#2H. Zhao (TU: Temple University)H-Index: 4
Last. A.J. Mamary (TU: Temple University)H-Index: 1
view all 8 authors...
Source
#1Y. Dotan (St. Luke's University Health Network)
#2W.B. Shapiro (TU: Temple University)
Last. A.J. Mamary (TU: Temple University)H-Index: 1
view all 9 authors...
Source
#1Dirk-Jan Slebos (UMCG: University Medical Center Groningen)H-Index: 33
#2Joseph Cicenia (Cleveland Clinic)H-Index: 7
Last. C. Egidio
view all 203 authors...
BACKGROUND: The Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) trial reported improvements in quality of life, pulmonary function, and exercise performance following endobronchial coil treatment. OBJECTIVES: The purpose of this post hoc analysis was to identify baseline predictors, including quantitative CT measures, that identify patients most likely to significantly benefit from endobronchial coil therapy. METHODS: Quantitative CT analysis by an independent radiology l...
Source
#1A. Gangemi (TU: Temple University)H-Index: 1
#2C.N. Myers (TU: Temple University)H-Index: 1
Last. A.J. Mamary (TU: Temple University)H-Index: 1
view all 12 authors...
1 CitationsSource
#1A. Gangemi (TU: Temple University)H-Index: 1
#2M. Kousha (St. John's Hospital)
Last. Gerard J. Criner (TU: Temple University)H-Index: 12
view all 13 authors...
Source
#1Yaniv Dotan (TU: Temple University)H-Index: 1
#2Anika Vaidy (TU: Temple University)H-Index: 1
Last. A. James Mamary (TU: Temple University)H-Index: 9
view all 11 authors...
Background Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) has an expected median survival of 3 months. Lung transplantation is a potentially lifesaving therapy for AE-IPF. However, the current knowledge of transplantation outcomes during AE-IPF is limited to a few small retrospective studies, reporting only 1-year post-transplantation survival. Methods Study population included patients with IPF consecutively listed for lung transplantation at a single institution between the years...
5 CitationsSource
1 CitationsSource
#1Jeong Yun (Harvard University)H-Index: 10
#2Andrew Lamb (Brigham and Women's Hospital)H-Index: 2
Last. R. Tal-SingerH-Index: 1
view all 212 authors...
Background Eosinophilic airway inflammation in patients with chronic obstructive pulmonary disease (COPD) is associated with exacerbations and responsivity to steroids, suggesting potential shared mechanisms with eosinophilic asthma. However, there is no consistent blood eosinophil count that has been used to define the increased exacerbation risk. Objective We sought to investigate blood eosinophil counts associated with exacerbation risk in patients with COPD. Methods Blood eosinophil counts a...
14 CitationsSource
123